Literature DB >> 33308899

Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?

K Khaddour1, M Ansstas1, J Visconti1, G Ansstas2.   

Abstract

Entities:  

Year:  2020        PMID： 33308899     DOI： 10.1016/j.annonc.2020.10.602

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.

Authors:  Karam Khaddour; Michael Ansstas; George Ansstas
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.